| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 55,7 k € | -22.2% | 71,6 k € | +93.9% | 36,9 k € | +11.4% | 33,1 k € | +62.6% | 20,4 k € | -53.3% | 43,7 k € | -20.8% | 55,2 k € | -10.5% | 61,7 k € | +17.6% | 52,4 k € | -15.5% | 62,0 k € | +46.6% | 42,3 k € | -1.1% | 42,8 k € | -10.6% | 47,9 k € | -11.2% | 53,9 k € | +15.6% | 46,6 k € | +1.7% | 45,9 k € | +6.4% | 43,1 k € | +32.7% | 32,5 k € | -35.4% | 50,2 k € | |
| EBITDA | 52,1 k € | -23.7% | 68,3 k € | +97.3% | 34,6 k € | +12.8% | 30,7 k € | +84.1% | 16,7 k € | -58.8% | 40,5 k € | -22.5% | 52,3 k € | -12.3% | 59,6 k € | +18.3% | 50,4 k € | -15.8% | 59,9 k € | +48.4% | 40,3 k € | -1.4% | 40,9 k € | -11.7% | 46,3 k € | -10.2% | 51,6 k € | +14.3% | 45,1 k € | +1.5% | 44,5 k € | +7.1% | 41,5 k € | +34.1% | 31,0 k € | -36.3% | 48,6 k € | |
| Operating profit | 48,6 k € | -17.0% | 58,5 k € | +239.2% | 17,2 k € | +4.1% | 16,6 k € | +1373.4% | -1,3 k € | -105.0% | 26,0 k € | -32.2% | 38,3 k € | -12.1% | 43,6 k € | +21.0% | 36,0 k € | -19.6% | 44,8 k € | +70.8% | 26,2 k € | -5.0% | 27,6 k € | -25.8% | 37,2 k € | -13.5% | 43,0 k € | +5.2% | 40,9 k € | +13.6% | 36,0 k € | +33.2% | 27,0 k € | +57.5% | 17,2 k € | -50.8% | 34,8 k € | |
| Profit/loss | 31,6 k € | -24.0% | 41,7 k € | +261.3% | 11,5 k € | +3.5% | 11,1 k € | +365.8% | -4,2 k € | -123.1% | 18,1 k € | -37.2% | 28,9 k € | -11.2% | 32,5 k € | +48.2% | 21,9 k € | -15.2% | 25,9 k € | +64.5% | 15,7 k € | -16.0% | 18,7 k € | -18.7% | 23,0 k € | -17.7% | 28,0 k € | +3.2% | 27,1 k € | +6.5% | 25,5 k € | +17.9% | 21,6 k € | +67.2% | 12,9 k € | -46.2% | 24,0 k € | |
| Equity | 115,2 k € | +14.6% | 100,6 k € | +41.8% | 70,9 k € | +2.2% | 69,4 k € | +0.8% | 68,8 k € | -5.7% | 73,0 k € | +29.3% | 56,5 k € | -1.9% | 57,6 k € | +55.3% | 37,1 k € | +5.5% | 35,2 k € | +20.0% | 29,3 k € | -40.9% | 49,6 k € | +60.6% | 30,9 k € | +10.9% | 27,8 k € | -6.7% | 29,8 k € | -8.7% | 32,7 k € | -70.0% | 109,1 k € | +24.7% | 87,5 k € | -23.6% | 114,6 k € | |
| Total assets | 152,6 k € | +16.1% | 131,4 k € | +29.1% | 101,8 k € | +1.3% | 100,5 k € | +6.5% | 94,3 k € | -8.0% | 102,5 k € | -5.2% | 108,1 k € | -3.5% | 112,0 k € | +15.3% | 97,1 k € | +8.9% | 89,1 k € | -1.2% | 90,2 k € | +10.9% | 81,4 k € | -0.2% | 81,6 k € | -11.6% | 92,3 k € | +31.3% | 70,3 k € | -56.1% | 160,3 k € | +19.9% | 133,7 k € | -12.4% | 152,6 k € | +0.7% | 151,6 k € | |
| Cash | 134,1 k € | +34.0% | 100,0 k € | +61.9% | 61,8 k € | +85.5% | 33,3 k € | +61.0% | 20,7 k € | +14.2% | 18,1 k € | -62.2% | 47,9 k € | +24.4% | 38,5 k € | +5.1% | 36,6 k € | +49.0% | 24,6 k € | -43.0% | 43,1 k € | +182.7% | 15,2 k € | -59.8% | 37,9 k € | -9.0% | 41,6 k € | +36.3% | 30,5 k € | -74.6% | 120,0 k € | +38.7% | 86,5 k € | +245.0% | 25,1 k € | -72.2% | 90,2 k € | |
| Debts | 37,4 k € | +21.3% | 30,8 k € | -0.1% | 30,8 k € | -0.6% | 31,0 k € | +21.8% | 25,5 k € | -13.0% | 29,3 k € | -43.3% | 51,6 k € | -5.1% | 54,4 k € | -9.4% | 60,0 k € | +11.2% | 54,0 k € | -11.4% | 60,9 k € | +92.6% | 31,6 k € | -37.6% | 50,7 k € | -21.4% | 64,5 k € | +59.4% | 40,5 k € | -68.3% | 127,6 k € | +419.1% | 24,6 k € | -62.3% | 65,1 k € | +75.9% | 37,0 k € | |
Private limited company profitable and well capitalised. Cash position rising (+34.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CABINET DE KINESITHERAPIE BORUCKI - QUEVRIN is a Private limited company incorporated in 2001. Its main activity is: Other human health activities. Its registered office is in Grâce-Hollogne.
Source: Belgian Official Gazette
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.